The Intestinal Immune System in Obesity and Insulin Resistance.
about
Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeObesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.Obesity and overweight: Impact on maternal and milk microbiome and their role for infant health and nutrition.Gut microbiome and chronic prostatitis/chronic pelvic pain syndromeBerberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.Regulatory Eosinophils in Inflammation and Metabolic Disorders.Antibiotic Exposure in Early Life Increases Risk of Childhood Obesity: A Systematic Review and Meta-Analysis.Roles of the gut in the metabolic syndrome: an overview.Immunologic impact of the intestine in metabolic disease.Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms.Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease.Exploiting a host-commensal interaction to promote intestinal barrier function and enteric pathogen tolerance.Gut REG3γ-Associated Lactobacillus Induces Anti-inflammatory Macrophages to Maintain Adipose Tissue Homeostasis.ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance.Introduction for the special issue on recent advances in drug delivery across tissue barriers.Adapting to obesity with adipose tissue inflammation.Effects of urban coarse particles inhalation on oxidative and inflammatory parameters in the mouse lung and colon.Adipose Tissue Inflammation Induces B Cell Inflammation and Decreases B Cell Function in Aging.Interplay of innate lymphoid cells and the microbiota.Integrated Immunomodulatory Mechanisms through which Long-Chain n-3 Polyunsaturated Fatty Acids Attenuate Obese Adipose Tissue Dysfunction.Role of innate lymphoid cells in obesity and metabolic disease (Review).Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance.Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health.Enzymatically synthesized megalo-type isomaltosaccharides enhance the barrier function of the tight junction in the intestinal epithelium.An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression.Inflammatory Bowel Disease and Immunonutrition: Novel Therapeutic Approaches Through Modulation of Diet and the Gut Microbiome.Cross-Talk Between Iron and Glucose Metabolism in the Establishment of Disease ToleranceObesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and OsteopeniaRutin and Its Combination With Inulin Attenuate Gut Dysbiosis, the Inflammatory Status and Endoplasmic Reticulum Stress in Paneth Cells of Obese Mice Induced by High-Fat Diet
P2860
Q26752744-0766F211-1C31-42A2-A941-49815312118EQ30239737-24FA2E18-5C14-4BE5-B1A5-B2DE105393F1Q30250363-EC5DB73E-1100-48D4-A1BA-3BBE7D6892C4Q36285208-D3C486A2-9C58-40B8-BF73-4C368DEF9E82Q37622726-F391A2CA-0FEE-4C08-99B6-AE6C0AE6F0A1Q37677658-C3550FAB-D470-4E2F-878E-0A86A0FA3368Q38647106-3E206370-546D-4290-8A03-4D7627278A31Q38780926-7583E67A-B9A4-4DD3-B784-BA2F497E4270Q39065615-60FF2DEA-450B-49E3-BA3C-CCDA9B735463Q39189861-E9FA2156-5DD7-4667-B1D1-87F0DF254A55Q39224276-38E60E7E-8E44-4265-B3E1-53125FA93B0BQ40185364-68015741-887B-4515-8646-3C0C6E260138Q41475223-EBFFA07A-9AC2-44C1-9521-35E195E20C96Q42373874-F9042723-D7A6-4364-967D-42D6085255DEQ42691823-69BB6591-387A-4848-A95E-EDDA5F7A8A66Q46611412-B0932E9A-CA70-4045-A5D8-5F6A5718B108Q47138517-8D0B7AD0-DE1B-4D6F-8E06-28BAE4CC7AC7Q48000215-78E61434-CFBA-48A1-8345-DDEAF1C522CEQ48151041-2D0B74B0-A4A0-45FC-89FB-1BA51D1C9483Q48216518-CB3BD322-BB18-4C7D-8D2D-2A91F5D4547AQ49187045-AA469CB9-A7D8-4231-8B66-91EA3BCF183CQ49205960-7E605606-4F2B-42E2-8FC2-2A837C251992Q49587798-BD3C5391-994A-4633-848D-CD93B107EC6EQ49664401-5C843FE1-90C8-432D-8AAD-22A67E95B300Q49744467-22D0C56C-6CA1-4B7D-BD92-7DE988691840Q52564079-D8B06E1A-CBB0-4FC5-A5F4-470F495EECFEQ58697850-017C22D6-F3F9-4F77-BBE3-837E69DAC1A9Q58773411-E2731675-E155-4985-9861-815CE90B7AC4Q59130055-5EDD13E9-C3A9-44C8-8B52-43C1F39DFF8F
P2860
The Intestinal Immune System in Obesity and Insulin Resistance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Intestinal Immune System in Obesity and Insulin Resistance.
@ast
The Intestinal Immune System in Obesity and Insulin Resistance.
@en
type
label
The Intestinal Immune System in Obesity and Insulin Resistance.
@ast
The Intestinal Immune System in Obesity and Insulin Resistance.
@en
prefLabel
The Intestinal Immune System in Obesity and Insulin Resistance.
@ast
The Intestinal Immune System in Obesity and Insulin Resistance.
@en
P2093
P1433
P1476
The Intestinal Immune System in Obesity and Insulin Resistance.
@en
P2093
Daniel A Winer
Helen Luck
Shawn Winer
P304
P356
10.1016/J.CMET.2016.01.003
P577
2016-02-03T00:00:00Z